Therapies targeting ACE2 provide a general strategy to prevent and treat infections by SARS-CoV-2 and its variants, as well as other potential coronaviruses that use the ACE2 receptor as an entry route for viral invasion [56]. This evidence concerns the gene ACE2 and infection.